BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1186774)

  • 1. Lymphocytotoxic antibody in inflammatory bowel disease. A family study.
    Korsmeyer SJ; Williams RC; Wilson ID; Strickland RG
    N Engl J Med; 1975 Nov; 293(22):1117-20. PubMed ID: 1186774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocytotoxic antibodies in patients with inflammatory bowel disease and their spouses--evidence for a transmissible agent.
    Strickland RG; Miller WC; Volpicelli NA; Gaeke RF; Wilson ID; Kirsner JB; Williams RC
    Clin Exp Immunol; 1977 Nov; 30(2):188-92. PubMed ID: 580077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum lymphocytotoxic and lymphocytophilic antibody activity in inflammatory bowel disease.
    Korsmeyer S; Strickland RG; Wilson ID; Williams RC
    Gastroenterology; 1974 Oct; 67(4):578-83. PubMed ID: 4607065
    [No Abstract]   [Full Text] [Related]  

  • 4. Lymphocytotoxic antibodies in family members of patients with systemic lupus erythematosus.
    DeHoratius RJ; Messner RP
    J Clin Invest; 1975 Jun; 55(6):1254-8. PubMed ID: 1133171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secretory immunoglobulin deficiency in a family with inflammatory bowel disease.
    Engstrom JF; Arvanitakis C; Sagawa A; Abdou NI
    Gastroenterology; 1978 Apr; 74(4):747-51. PubMed ID: 415931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CARD15 mutations in Dutch familial and sporadic inflammatory bowel disease and an overview of European studies.
    van der Linde K; Boor PP; Houwing-Duistermaat JJ; Crusius BJ; Wilson PJ; Kuipers EJ; de Rooij FW
    Eur J Gastroenterol Hepatol; 2007 Jun; 19(6):449-59. PubMed ID: 17489054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antineutrophil cytoplasmic antibodies in relatives of patients with inflammatory bowel disease.
    Papo M; Quer JC; Pastor RM; García-Pardo G; Prats E; Mirapeix E; Rodríguez R; Richart C
    Am J Gastroenterol; 1996 Aug; 91(8):1512-5. PubMed ID: 8759652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-nucleic acid antibodies in systemic lupus erythematosus patients and their families. Incidence and correlation with lymphocytotoxic antibodies.
    DeHoratius RJ; Pillarisetty R; Messner RP; Talal N
    J Clin Invest; 1975 Nov; 56(5):1149-54. PubMed ID: 1081099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating immune complexes in inflammatory bowel disease.
    Jewell DP; MacLennan IC
    Clin Exp Immunol; 1973 Jun; 14(2):219-26. PubMed ID: 4197968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological aspects of inflammatory bowel disease.
    Whorwell PJ; Wright R
    Clin Gastroenterol; 1976 May; 5(2):303-21. PubMed ID: 1037288
    [No Abstract]   [Full Text] [Related]  

  • 11. Characteristics of isolated intestinal mucosal lymphoid cells in inflammatory bowel disease.
    Bookman MA; Bull DM
    Gastroenterology; 1979 Sep; 77(3):503-10. PubMed ID: 313352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of MALTectomy (appendectomy and tonsillectomy) and inflammatory bowel disease: a familial case-control study.
    López Ramos D; Gabriel R; Cantero Perona J; Moreno Otero R; Fernández Bermejo M; Maté Jiménez J
    Rev Esp Enferm Dig; 2001 May; 93(5):303-14. PubMed ID: 11488108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Familial prevalence in chronic intestinal inflammatory disease. Differences among groups of patients with and without a familial history].
    Nos P; Argüello L; Hoyos M; Ramírez JJ; Hinojosa J; Molés JR; García A; Berenguer M; Berenguer J
    Rev Esp Enferm Dig; 1996 Jul; 88(7):470-4. PubMed ID: 8924324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-neutrophil cytoplasmic antibodies in Brazilian patients with inflammatory bowel disease.
    Cabral VL; Miszputen SJ; Catapani WR
    Hepatogastroenterology; 2003; 50(50):412-5. PubMed ID: 12749235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial expression of anti-Saccharomyces cerevisiae Mannan antibodies in Crohn's disease and ulcerative colitis: a GISC study.
    Annese V; Andreoli A; Andriulli A; Dinca R; Gionchetti P; Latiano A; Lombardi G; Piepoli A; Poulain D; Sendid B; Colombel JF
    Am J Gastroenterol; 2001 Aug; 96(8):2407-12. PubMed ID: 11513182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory bowel disease. An epidemiological and genetic study.
    Monsén U
    Acta Chir Scand Suppl; 1990; 559():1-42. PubMed ID: 2092567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smoking and inflammatory bowel disease in families.
    Smith MB; Lashner BA; Hanauer SB
    Am J Gastroenterol; 1988 Apr; 83(4):407-9. PubMed ID: 3348193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral blood mononuclear cells from patients with inflammatory bowel disease exhibit normal function in the allogeneic and autologous mixed leukocyte reaction and cell-mediated lympholysis.
    MacDermott RP; Bragdon MJ; Thurmond RD
    Gastroenterology; 1984 Mar; 86(3):476-84. PubMed ID: 6229444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum lymphocytotoxins in inflammatory bowel disease. Studies of frequency and specificity for lymphocyte subpopulations.
    Strickland RG; Friedler EM; Henderson CA; Wilson ID; Williams RD
    Clin Exp Immunol; 1975 Sep; 21(3):384-93. PubMed ID: 1081934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent developments in nonspecific inflammatory bowel disease (second of two parts).
    Kirsner JB; Shorter RG
    N Engl J Med; 1982 Apr; 306(14):837-48. PubMed ID: 7038490
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.